Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation.
Uojima H, Yamasaki K, Sugiyama M, Kage M, Ishii N, Shirabe K, Hidaka H, Kusano C, Murakawa M, Asahina Y, Nishimura T, Iijima H, Sakamoto K, Ito K, Amano K, Kawaguchi T, Tamaki N, Kurosaki M, Suzuki T, Matsuura K, Taketomi A, Joshita S, Umemura T, Nishina S, Hino K, Toyoda H, Yatsuhashi H, Mizokami M. Uojima H, et al. Among authors: murakawa m. J Gastroenterol. 2024 Apr 16. doi: 10.1007/s00535-024-02100-3. Online ahead of print. J Gastroenterol. 2024. PMID: 38625546
New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease.
Uojima H, Nakabayashi K, Yamasaki K, Sugiyama M, Ishii N, Shirabe K, Kyoutou T, Ueda K, Takahama Y, Tamaki N, Kurosaki M, Hidaka H, Kusano C, Amano K, Kawaguchi T, Taketomi A, Joshita S, Umemura T, Murakawa M, Asahina Y, Suzuki T, Matsuura K, Nishimura T, Iijima H, Sakamoto K, Ito K, Nishina S, Hino K, Toyoda H, Yatsuhashi H, Kage M, Mizokami M. Uojima H, et al. Among authors: murakawa m. J Gastroenterol. 2023 Dec;58(12):1252-1260. doi: 10.1007/s00535-023-02043-1. Epub 2023 Oct 8. J Gastroenterol. 2023. PMID: 37812281
Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs.
Nakagawa M, Nawa N, Takeichi E, Shimizu T, Tsuchiya J, Sato A, Miyoshi M, Kawai-Kitahata F, Murakawa M, Nitta S, Itsui Y, Azuma S, Kakinuma S, Fujiwara T, Watanabe M, Tanaka Y, Asahina Y; Ochanomizu Liver Conference Study Group. Nakagawa M, et al. Among authors: murakawa m. J Gastroenterol. 2020 Oct;55(10):990-999. doi: 10.1007/s00535-020-01715-6. Epub 2020 Aug 8. J Gastroenterol. 2020. PMID: 32770465
Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C.
Maekawa S, Sato M, Kuratomi N, Inoue T, Suzuki Y, Tatsumi A, Miura M, Matsuda S, Muraoka M, Nakakuki N, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Sato T, Sakamoto M, Murakawa M, Nakagawa M, Asahina Y, Enomoto N. Maekawa S, et al. Among authors: murakawa m. J Gastroenterol. 2018 Jun;53(6):780-786. doi: 10.1007/s00535-017-1405-3. Epub 2017 Nov 1. J Gastroenterol. 2018. PMID: 29094205
Association of serum interferon-λ3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct-acting antiviral agents.
Inoue-Shinomiya E, Murakawa M, Asahina Y, Nakagawa M, Tsuchiya J, Sato A, Tsunoda T, Miyoshi M, Nitta S, Kawai-Kitahata F, Itsui Y, Azuma S, Kakinuma S, Murata K, Mizokami M, Watanabe M. Inoue-Shinomiya E, et al. Among authors: murakawa m. Hepatol Res. 2019 May;49(5):500-511. doi: 10.1111/hepr.13307. Epub 2019 Feb 7. Hepatol Res. 2019. PMID: 30623518
Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C.
Murakawa M, Asahina Y, Nakagawa M, Sakamoto N, Nitta S, Kusano-Kitazume A, Watanabe T, Kawai-Kitahata F, Otani S, Taniguchi M, Goto F, Nishimura-Sakurai Y, Itsui Y, Azuma S, Kakinuma S, Watanabe M. Murakawa M, et al. J Gastroenterol Hepatol. 2015 Jun;30(6):1075-84. doi: 10.1111/jgh.12902. J Gastroenterol Hepatol. 2015. PMID: 25611696
Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
Kawai-Kitahata F, Asahina Y, Tanaka S, Kakinuma S, Murakawa M, Nitta S, Watanabe T, Otani S, Taniguchi M, Goto F, Nagata H, Kaneko S, Tasaka-Fujita M, Nishimura-Sakurai Y, Azuma S, Itsui Y, Nakagawa M, Tanabe M, Takano S, Fukasawa M, Sakamoto M, Maekawa S, Enomoto N, Watanabe M. Kawai-Kitahata F, et al. Among authors: murakawa m. J Gastroenterol. 2016 May;51(5):473-86. doi: 10.1007/s00535-015-1126-4. Epub 2015 Nov 9. J Gastroenterol. 2016. PMID: 26553052
Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8+ T cell quality.
Takahama S, Yoshio S, Masuta Y, Murakami H, Sakamori R, Kaneko S, Honda T, Murakawa M, Sugiyama M, Kurosaki M, Asahina Y, Takehara T, Appay V, Kanto T, Yamamoto T. Takahama S, et al. Among authors: murakawa m. Front Immunol. 2023 Oct 18;14:1257113. doi: 10.3389/fimmu.2023.1257113. eCollection 2023. Front Immunol. 2023. PMID: 37920475 Free PMC article.
Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy.
Nagata H, Nakagawa M, Nishimura-Sakurai Y, Asano Y, Tsunoda T, Miyoshi M, Kaneko S, Goto F, Otani S, Kawai-Kitahata F, Murakawa M, Nitta S, Itsui Y, Azuma S, Kakinuma S, Tojo N, Tohda S, Asahina Y, Watanabe M; Ochanomizu Liver Conference Study Group. Nagata H, et al. Among authors: murakawa m. Hepatol Int. 2016 Nov;10(6):956-964. doi: 10.1007/s12072-016-9754-1. Epub 2016 Jul 19. Hepatol Int. 2016. PMID: 27435935
Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors.
Kaneko S, Asahina Y, Nakagawa M, Murakawa M, Miyazaki Y, Asakage T, Fukuda S, Namiki T, Kano Y, Nagata M, Tsuchiya J, Miyoshi M, Kitahata-Kawai F, Nitta S, Itsui Y, Kakinuma S, Okamoto R. Kaneko S, et al. Among authors: murakawa m. Hepatol Res. 2023 May;53(5):450-459. doi: 10.1111/hepr.13878. Epub 2023 Jan 27. Hepatol Res. 2023. PMID: 36626292
313 results